These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26895269)

  • 1. A Critical Analysis of Concentration and Competition in the Indian Pharmaceutical Market.
    Mehta A; Hasan Farooqui H; Selvaraj S
    PLoS One; 2016; 11(2):e0148951. PubMed ID: 26895269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmaceutical market in Mexico: size, value, and concentration].
    Torres Guerra S; Gutiérrez JP
    Rev Panam Salud Publica; 2009 Jul; 26(1):46-50. PubMed ID: 19814881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation.
    Feldman R; Fulton BD; Godwin JR; Scheffler RM
    J Health Polit Policy Law; 2022 Oct; 47(5):583-607. PubMed ID: 35576314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of a Hirschman-Herfindahl index without complete market share information.
    Nauenberg E; Alkhamisi M; Andrijuk Y
    Health Econ; 2004 Jan; 13(1):87-94. PubMed ID: 14724896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monopoly, monopsony, and market definition: an antitrust perspective on market concentration among health insurers.
    Hyman DA; Kovacic WE
    Health Aff (Millwood); 2004; 23(6):25-8. PubMed ID: 15537581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study of the Market Configuration of the Japanese Pharmaceutical Market Using the Gini Coefficient and Herfindahl-Hirschman Index.
    Shibata S; Fukumoto D; Suzuki T; Ozaki K
    Ther Innov Regul Sci; 2020 Sep; 54(5):1047-1055. PubMed ID: 31989539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of market (industry) concentration based on value validity.
    Kvålseth TO
    PLoS One; 2022; 17(7):e0264613. PubMed ID: 35849576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference pricing system and competition: case study from Portugal.
    Portela C
    Croat Med J; 2009 Oct; 50(5):429-39. PubMed ID: 19839066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Market competition influences renal transplantation risk and outcomes.
    Adler JT; Sethi RK; Yeh H; Markmann JF; Nguyen LL
    Ann Surg; 2014 Sep; 260(3):550-6; discussion 556-7. PubMed ID: 25115431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of market competition on hospital performance for heart failure.
    Maeda JL; LoSasso AT
    Am J Manag Care; 2011 Dec; 17(12):816-22. PubMed ID: 22216752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of market concentration on health care price and quality in hospital markets in Ibadan, Nigeria.
    Awoyemi BO; Olaniyan O
    J Mark Access Health Policy; 2021 Jun; 9(1):1938895. PubMed ID: 34221255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of the pharmaceutical market in Iran using concentration indices.
    Mohseni M; Gorji HA; Ahadinezhad B; Khosravizadeh O; Keykaleh MS; Moosavi A; Mohtashamzadeh B
    Electron Physician; 2017 Apr; 9(4):4251-4254. PubMed ID: 28607663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the Indian market of anti-tuberculosis drugs: focus on the utilisation of rifampicin-based products.
    Catalani E
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S289-91; discussion S317-21. PubMed ID: 10593707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status.
    Ligade VS; Thakar TM; Dengale SJ
    Trop Med Int Health; 2019 Feb; 24(2):238-246. PubMed ID: 30422371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Market Competition and Health Outcomes in Hemodialysis.
    Erickson KF; Zheng Y; Ho V; Winkelmayer WC; Bhattacharya J; Chertow GM
    Health Serv Res; 2018 Oct; 53(5):3680-3703. PubMed ID: 29468675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation.
    Cho PS; Saidi RF; Cutie CJ; Ko DS
    Int J Organ Transplant Med; 2015; 6(4):141-9. PubMed ID: 26576259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors].
    Mahlich JC; Stadler I
    Gesundheitswesen; 2012 Jan; 74(1):23-8. PubMed ID: 21154203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hospital market competition on endovascular aneurysm repair adoption and outcomes.
    Sethi RK; Henry AJ; Hevelone ND; Lipsitz SR; Belkin M; Nguyen LL
    J Vasc Surg; 2013 Sep; 58(3):596-606. PubMed ID: 23684424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.
    Hong SH; Shepherd MD; Scoones D; Wan TT
    J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.